Skip to main content

Table 1 Laboratories with molecular diagnostics in surveyed regions

From: Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation

Characteristics

Regions

All

Dar es Salaam

Mbeya

Morogoro

Mwanza

Shinyanga

Laboratories with molecular diagnostics for MDR-TB diagnosis per District. No.(%)

11 (39)

5 (42)

2 (50)

1 (25)

1 (25)

2 (50)

Number of samples received for XpertMTB/RIF per day. No/ median (IQR)

12 (11–22)

20 (14–24)

11 (10–12)

12 (−)

10 (−)

21 (11–30)

Number of samples tested in XpertMTB/RIF per day. No/Median (IQR)

12 (12–14)

12 (12–16)

9 (6–12)

8 (−)

10 (−)

18 (12–24)

Number of staff for operating the XpertMTB/RIF per laboratory

3 (2–6)

3 (2–3)

7 (2–11)

2 (−)

5 (−)

9 (7–10)

Number of staff trained for operating the XpertMTB/RIF. No./Median (IQR)

3 (2–4)

3 (2–3)

2 (−)

3 (−)

2 (−)

4 (−)

Estimated months XpertMTB/RIF was not working due to several reasons

2 (1–4)

3 (2–5)

3 (1–4)

2 (−)

1 (−)

2 (1–2)